Literature DB >> 8095424

Anti-somatostatin antibody enhances the rate of hippocampal kindling in rats.

A Monno1, M Rizzi, R Samanin, A Vezzani.   

Abstract

A somatostatin-specific antibody (Ab) (1:250) was continuously infused into the stimulated dorsal hippocampus of rats from 4 days before to 26 days after the beginning of kindling or until the first stage 5. Controls received boiled Ab. The number of stimulations to the first stage 5 were reduced by 41 +/- 4% (P < 0.01, Student's t-test) in animals infused with the Ab compared to controls. The cumulative after-discharge in the stimulated hippocampus was slightly, although not significantly, reduced. Kindling was not affected when the Ab was infused only during the first 10 stimulations (stage 2). Histological analysis showed no neurotoxic effects in the hippocampus as a consequence of Ab infusion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095424     DOI: 10.1016/0006-8993(93)90255-l

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Somatostatin inhibits excitatory transmission at rat hippocampal synapses via presynaptic receptors.

Authors:  S Boehm; H Betz
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

2.  Highly specific neuron loss preserves lateral inhibitory circuits in the dentate gyrus of kainate-induced epileptic rats.

Authors:  P S Buckmaster; A L Jongen-Rêlo
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

3.  Somatostatin type-2 receptor activation inhibits glutamate release and prevents status epilepticus.

Authors:  Maxim Kozhemyakin; Karthik Rajasekaran; Marko S Todorovic; Samuel L Kowalski; Corinne Balint; Jaideep Kapur
Journal:  Neurobiol Dis       Date:  2013-03-05       Impact factor: 5.996

4.  Somatostatin in medium-sized aspiny interneurons of striatum is responsible for their preservation in quinolinic acid and N-methyl-D-asparate-induced neurotoxicity.

Authors:  Ujendra Kumar
Journal:  J Mol Neurosci       Date:  2008-05-16       Impact factor: 3.444

Review 5.  Somatostatin: an endogenous antiepileptic.

Authors:  Melanie K Tallent; Cuie Qiu
Journal:  Mol Cell Endocrinol       Date:  2007-12-14       Impact factor: 4.102

Review 6.  Neuropeptides as targets for the development of anticonvulsant drugs.

Authors:  Elke Clynen; Ann Swijsen; Marjolein Raijmakers; Govert Hoogland; Jean-Michel Rigo
Journal:  Mol Neurobiol       Date:  2014-04-06       Impact factor: 5.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.